Stay updated on Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial

Sign up to get notified when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; Deleted Revision: v3.4.2. This seems to be a system update rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-03-12T20:31:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no visible edits to core study data, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:17.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is listed, replacing v3.4.0, with no substantive study content changed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:50:51.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T21:32:47.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T04:29:00.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new consolidated Locations section has been added with state listings (California, New York, Oregon, Pennsylvania, Utah, Wisconsin) and the previous separate state location headings have been removed. This improves visibility of where the study is conducted.
    Difference
    0.7%
    Check dated 2025-12-23T22:05:15.000Z thumbnail image

Stay in the know with updates to Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.